Treat-and-extend comparable to monthly injections in AMD

The TREND study recruited 650 treatment-naive patients with active choroidal neovascularization secondary to AMD in 90 centers across 18 countries, randomly assigned to treat-and-extend or monthly ranibizumab 0.5 mg. According to the authors, "the [treat-and-extend] regimen considers these vary...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Primary Care Optometry News 2017-10, Vol.22 (10), p.6-6
1. Verfasser: Cimberle, Michela
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
Beschreibung
Zusammenfassung:The TREND study recruited 650 treatment-naive patients with active choroidal neovascularization secondary to AMD in 90 centers across 18 countries, randomly assigned to treat-and-extend or monthly ranibizumab 0.5 mg. According to the authors, "the [treat-and-extend] regimen considers these varying patient requirements, thus allowing for a tailored follow-up schedule" - by Michela Cimberle РИМ Reference: Silva R, et al.
ISSN:1081-6437